David Rosen, a partner and member of the Life Sciences and Nanotechnology Industry Teams, will be moderating a panel for the Tech Council of Maryland entitled, “Nanomedicine, Opportunities and Challenges.” The session will be taking place at John Hopkins University on September 12, 2007.
The panel will discuss the promises as well as some of the challenges are to creating these new therapies that may be safer and more effective in treating life-threatening diseases.
Panelists include:
- Dr. Hamid Ghandehari, Director, University of Maryland School of Pharmacy, Center for Nanomedicine and Cellular Delivery, Department of Pharmaceutical Sciences
- Dr. Chiming Wei, Department of Surgery, The Johns Hopkins School of Medicine and President, American Academy of Nanomedicine
- Dr. Lawrence Tamarkin, President & CEO, CytImmune Sciences, Inc.
People
Related Insights
July 11, 2025
Foley Viewpoints
Department of Justice Launches Program to Reward Antitrust Whistleblowers with Shares of Criminal Fines
On July 8, 2025, the U.S. Department of Justice, Antitrust Division (“Antitrust Division”) announced a new “Whistleblower Rewards…
July 23, 2025
Events
Healthcare Supply Chain Compliance Challenges: Vendor Management, Contract Negotiation, Tariff Impact
Foley partner Monica Chmielewski, vice chair of the firm’s Health Care Practice Group, is speaking in Strafford’s upcoming webinar titled “Healthcare Supply Chain Compliance Challenges: Vendor Management, Contract Negotiation, Tariff Impact” on July 23.
September 30, 2025
Events
FDA Regulation of AI-Enabled Medical Devices
Foley partner Kyle Faget, co-chair of the firm’s Medical Devices Area of Focus, is speaking at the American Bar Association Health Law Section’s Healthcare Delivery & Innovation Conference on September 30.